Samuel Backenroth, CFO, Treasurer & Secretary at NeuBase Therapeutics, holds 11.63K shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Samuel Backenroth Bought $1,000 shares of NeuBase Therapeutics on May 04, 2020 for an estimated value of 6.00K.